Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Not Confirmed
Not Confirmed
04-05 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Industry Trade Show
Not Confirmed
04-05 March, 2026
Digital content

09 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/09/3234416/0/en/Memo-Therapeutics-AG-Enters-into-a-Collaboration-and-Option-Agreement-with-CSL-for-Development-of-Recombinant-Polyclonal-IgG-Technology.html

09 Feb 2026
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/csl-signs-research-collab-option-linked-memo-therapeutics-immunoglobulin-antibody-tech

09 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/09/3216009/0/en/Memo-Therapeutics-AG-Publishes-BKPyV-Infection-Disease-Burden-Study-in-the-Journal-of-Patient-Reported-Outcomes.html

18 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/18/3207550/0/en/Memo-Therapeutics-AG-s-Potravitug-Granted-Orphan-Designation-in-the-European-Union.html

07 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/07/3183523/0/en/Memo-Therapeutics-AG-Presents-Long-Term-Follow-Up-Data-from-its-Phase-II-SAFE-KIDNEY-Trial-of-Potravitug-and-Real-World-Data-on-the-Challenges-and-Re-source-Utilization-of-Managing.html

19 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/19/3135566/0/en/Memo-Therapeutics-AG-Publishes-Phase-I-Safety-Tolerability-and-Pharmacokinetics-Study-for-Neutralizing-Antibody-Targeting-BKPyV-Infection-in-Clinical-and-Translational-Science.html
ABOUT THIS PAGE